TMDX
TransMedics Beats Estimates with Quarterly Sales Surge
TransMedics reported Q3 2026 revenue growth of 41% and raised full-year guidance. The company also received new FDA approvals and appointed a new CFO amidst strong momentum.
TMDX news
Latest 3 stories · newest Nov 5, 2026
TMDX
TransMedics appoints Fernando Araujo as CFO
TransMedics announced the appointment of Fernando Araujo as its new Chief Financial Officer, succeeding Gerardo Hernandez who is transitioning to a LATAM role. Concurrently, the company reiterated its 2026 financial outlook.
TMDX
TransMedics amends 2019 stock plan with expanded share reserve and extended term.
TransMedics Group amended its 2019 Stock Incentive Plan to increase the share reserve to 5.39 million shares and extend the plan term to June 1, 2036, while implementing a one-year minimum vesting requirement for awards granted after January 1, 2027. The amendments reflect the company's ongoing equi…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same TMDX feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/TMDX/newsSTART FREE